Spots Global Cancer Trial Database for Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
Official Title: A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Study ID: NCT00458601
Conditions
Study Description
Brief Summary: This study is designed to evaluate the clinical activity of CDX-110 vaccination when given with standard of care treatment (maintenance temozolomide therapy). Study treatment will be given until disease progression and patients will be followed for long-term survival information. Efficacy will be measured by the progression-free survival status at 5.5 months from the date of first dose.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Celldex Investigational Site, Orange, California, United States
Celldex Investigational Site, San Francisco, California, United States
Celldex Investigational Site, San Francisco, California, United States
Celldex Investigational Site, Stanford, California, United States
Celldex Investigational Site, Stanford, California, United States
Celldex Investigational Site, New Haven, Connecticut, United States
Celldex Investigational Site, New Haven, Connecticut, United States
Celldex Investigational Site, New Haven, Connecticut, United States
Celldex Investigational Site, Gainesville, Florida, United States
Celldex Investigational Site, Chicago, Illinois, United States
Celldex Investigational Site, Evanston, Illinois, United States
Celldex Investigational Site, Boston, Massachusetts, United States
Celldex Investigational Site, Lansing, Michigan, United States
Celldex Investigational Site, Saginaw, Michigan, United States
Celldex Investigational Site, Saginaw, Michigan, United States
Celldex Investigational Site, Hackensack, New Jersey, United States
Celldex Investigational Site, Amherst, New York, United States
Celldex Investigational Site, New York, New York, United States
Celldex Investigational Site, New York, New York, United States
Celldex Investigational Site, Durham, North Carolina, United States
Celldex Investigational Site, Cincinnati, Ohio, United States
Celldex Investigational Site, Cincinnati, Ohio, United States
Celldex Investigational Site, Cincinnati, Ohio, United States
Celldex Investigational Site, Cleveland, Ohio, United States
Celldex Investigational Site, Cleveland, Ohio, United States
Celldex Investigational Site, Orange Village, Ohio, United States
Celldex Investigational Site, West Chester, Ohio, United States
Celldex Investigational Site, Westlake, Ohio, United States
Celldex Investigational Site, Philadelphia, Pennsylvania, United States
Celldex Investigational Site, Houston, Texas, United States
Celldex Investigational Site, San Antonio, Texas, United States
Celldex Investigational Site, Salt Lake City, Utah, United States
Celldex Investigational Site, Charlottesville, Virginia, United States
Celldex Investigational Site, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
